Serum hyaluronic acid as an early prognostic marker in biliary atresia

J Pediatr Surg. 2001 Mar;36(3):443-6. doi: 10.1053/jpsu.2001.21622.

Abstract

Purpose: The aim of this study was to assess whether serum concentrations of hyaluronic acid (HA), measured at diagnosis is an early biochemical marker of prognosis in biliary atresia.

Methods: Serum HA was measured at diagnosis using a radiometric assay in 84 infants with biliary atresia (BA), and related to outcome by 5 years of age.

Results: Serum HA was higher in the 29 patients who died or required liver transplant by 5 years of age compared with the 56 who survived to 5 years without transplant (490 +/- 216 microg/L v 262 +/- 163 microg/L; P <.001, 95% confidence intervals of the difference 145 to 311 microg/L).

Conclusion: High serum concentrations of HA at diagnosis may help to identify at an early stage those patients with BA who have a poor prognosis and will require liver transplant by 5 years of age.

MeSH terms

  • Actuarial Analysis
  • Age Factors
  • Aspartate Aminotransferases / blood
  • Biliary Atresia / blood
  • Biliary Atresia / diagnosis*
  • Biliary Atresia / mortality
  • Biliary Atresia / surgery*
  • Bilirubin / blood
  • Biomarkers
  • Disease-Free Survival
  • Female
  • Humans
  • Hyaluronic Acid / blood*
  • Infant
  • Infant, Newborn
  • Male
  • Portoenterostomy, Hepatic*
  • Prognosis
  • Prospective Studies
  • ROC Curve

Substances

  • Biomarkers
  • Hyaluronic Acid
  • Aspartate Aminotransferases
  • Bilirubin